Omeprazole magnesium
- Product NDC
- 66993-426
- Requested package NDC
- 66993-426-38
- 11-digit product format
- 669930426
- Labeler code
- 66993
- Product ID
- 66993-426_7658a299-de72-4ce6-9910-a37ef272dcd0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- omeprazole magnesium
- Dosage form
- GRANULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Prasco Laboratories
- Application
- NDA022056
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2022-09-30
- Marketing end
- 0000-00-00
- Substance
- OMEPRAZOLE MAGNESIUM
- Active strength
- 3 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 66993-426 | 66993-426-38 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022056-001 | PRILOSEC | OMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | |
| N022056-002 | PRILOSEC | OMEPRAZOLE MAGNESIUM | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022056-001 | PRILOSEC | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD | 2008-03-20 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022056-002 | PRILOSEC | EQ 10MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE / ORAL | RLD, RS | 2008-03-20 | 74a2ff9319b5… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N022056-001 | 6428810 | 2019-11-03 | U-1817 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022056-001 | 6428810 | 2019-11-03 | U-864 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022056-002 | 6428810 | 2019-11-03 | U-864 | Drug product | 74a2ff9319b5… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022056-001 | 6428810 | 2019-11-03 | U-1817 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022056-001 | 6428810 | 2019-11-03 | U-864 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022056-002 | 6428810 | 2019-11-03 | U-864 | Drug product | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022056-001 | 6428810 | 2019-11-03 | U-1817 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022056-001 | 6428810 | 2019-11-03 | U-864 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022056-002 | 6428810 | 2019-11-03 | U-864 | Drug product | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022056-001 | 6428810 | 2019-11-03 | U-1817 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022056-001 | 6428810 | 2019-11-03 | U-864 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022056-002 | 6428810 | 2019-11-03 | U-864 | Drug product | ea99ee380514… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prilosec | OMEPRAZOLE MAGNESIUM | Covis Pharma US, Inc | b6761f84-53ac-4745-a8c8-1e5427d7e179 | 2024-03-19 | Warnings, Adverse reactions | 022056 NDA022056 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 66993-426-38 | 66993042638 | 30 GRANULE, DELAYED RELEASE in 1 CARTON (66993-426-38) | 2022-09-30 | 0000-00-00 | No | No | Current |